Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.
2.

Polyosides (encapsulated bacteria).

Lindberg AA.

C R Acad Sci III. 1999 Nov;322(11):925-32. Review.

PMID:
10646085
3.

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity.

Dilts DA, Riesenfeld-Orn I, Fulginiti JP, Ekwall E, Granert C, Nonenmacher J, Brey RN, Cryz SJ, Karlsson K, Bergman K, Thompson T, Hu B, Brückner AH, Lindberg AA.

Vaccine. 2000 Feb 14;18(15):1473-84.

PMID:
10618545
4.

Glycoprotein conjugate vaccines.

Lindberg AA.

Vaccine. 1999 Oct 1;17 Suppl 2:S28-36. Review.

PMID:
10506406
5.

Vaccination against enteric pathogens: from science to vaccine trials.

Lindberg AA.

Curr Opin Microbiol. 1998 Feb;1(1):116-24. Review.

PMID:
10066464
6.
7.
8.

Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis.

Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B.

J Clin Pathol. 1997 Jun;50(6):513-20.

9.

Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates.

Klee SR, Tzschaschel BD, Singh M, Fält I, Lindberg AA, Timmis KN, Guzmán CA.

Microb Pathog. 1997 Jun;22(6):363-76.

PMID:
9188091
10.

Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.

Klee SR, Tzschaschel BD, Fält I, Kärnell A, Lindberg AA, Timmis KN, Guzmán CA.

Infect Immun. 1997 Jun;65(6):2112-8.

11.
12.
13.

In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis.

Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B.

Infect Immun. 1997 Feb;65(2):739-49.

15.

Pathogenesis and immune responses in shigellosis.

Raqib R, Wretlind B, Lindberg AA, Ljungdahl A, Andersson J.

Ann N Y Acad Sci. 1996 Oct 25;797:299-301. No abstract available.

PMID:
8993387
16.

Persistence of nontypeable Haemophilus influenzae in adenoid macrophages: a putative colonization mechanism.

Forsgren J, Samuelson A, Borrelli S, Christensson B, Jonasson J, Lindberg AA.

Acta Otolaryngol. 1996 Sep;116(5):766-73.

PMID:
8908258
18.

Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis.

Islam D, Wretlind B, Hammarström L, Christensson B, Lindberg AA.

APMIS. 1996 Jul-Aug;104(7-8):563-74.

PMID:
8920810
20.

Dissociation between cytokine mRNA expression and protein production in shigellosis.

Raqib R, Ljungdahl A, Lindberg AA, Wretlind B, Andersson U, Andersson J.

Eur J Immunol. 1996 May;26(5):1130-8.

PMID:
8647178
21.

Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis.

Islam D, Wretlind B, Lindberg AA, Christensson B.

Infect Immun. 1996 Apr;64(4):1391-9.

22.

Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection.

Raqib R, Ljungdahl A, Lindberg AA, Andersson U, Andersson J.

Gut. 1996 Mar;38(3):328-36.

23.

Glycoconjugate vaccines: future combinations.

Paradiso PR, Lindberg AA.

Dev Biol Stand. 1996;87:269-75. Review.

PMID:
8854027
24.

Recent trends in the developments of bacterial vaccines.

Lindberg AA, Pillai S.

Dev Biol Stand. 1996;87:59-71. Review. No abstract available.

PMID:
8854003
26.

Heterogeneity of Brucella abortus lipopolysaccharides.

Freer E, Rojas N, Weintraub A, Lindberg AA, Moreno E.

Res Microbiol. 1995 Sep;146(7):569-78. Review.

PMID:
8577998
27.
28.

Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.

Fält IC, Schweda EK, Klee S, Singh M, Floderus E, Timmis KN, Lindberg AA.

J Bacteriol. 1995 Sep;177(18):5310-5.

30.

Structural studies of the saccharide part of the cell envelope lipooligosaccharide from Haemophilus influenzae strain galEgalK.

Schweda EK, Jansson PE, Moxon ER, Lindberg AA.

Carbohydr Res. 1995 Aug 11;272(2):213-24.

PMID:
7497478
33.

Turnover of nonencapsulated Haemophilus influenzae in the nasopharynges of otitis-prone children.

Samuelson A, Freijd A, Jonasson J, Lindberg AA.

J Clin Microbiol. 1995 Aug;33(8):2027-31.

34.
35.

Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose.

Borrelli S, Roggen EL, Hendriksen D, Jonasson J, Ahmed HJ, Piot P, Jansson PE, Lindberg AA.

Infect Immun. 1995 Jul;63(7):2665-73.

37.
38.
39.

Identification of Shigella and enteroinvasive Escherichia coli strains by a virulence-specific, monoclonal antibody-based enzyme immunoassay.

Floderus E, Pál T, Karlsson K, Lindberg AA.

Eur J Clin Microbiol Infect Dis. 1995 Feb;14(2):111-7.

PMID:
7758475
40.

Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma.

Raqib R, Wretlind B, Andersson J, Lindberg AA.

J Infect Dis. 1995 Feb;171(2):376-84.

PMID:
7531208
41.

Characterization of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations.

Samuelson A, Borrelli S, Gustafson R, Hammarström L, Smith CI, Jonasson J, Lindberg AA.

Scand J Infect Dis. 1995;27(4):303-13.

PMID:
8658061
43.

Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Raqib R, Lindberg AA, Wretlind B, Bardhan PK, Andersson U, Andersson J.

Infect Immun. 1995 Jan;63(1):289-96.

44.

The history of live bacterial vaccines.

Lindberg AA.

Dev Biol Stand. 1995;84:211-9.

PMID:
7796956
45.

Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers.

Kärnell A, Li A, Zhao CR, Karlsson K, Nguyen BM, Lindberg AA.

Vaccine. 1995 Jan;13(1):88-99.

PMID:
7762285
46.

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.

Sztein MB, Wasserman SS, Tacket CO, Edelman R, Hone D, Lindberg AA, Levine MM.

J Infect Dis. 1994 Dec;170(6):1508-17.

PMID:
7995991
47.
49.

Structural studies of the O-antigenic polysaccharides of Escherichia coli O3 and the enteroaggregative Escherichia coli strain 17-2.

Medina EC, Widmalm G, Weintraub A, Vial PA, Levine MM, Lindberg AA.

Eur J Biochem. 1994 Aug 15;224(1):191-6.

50.

Mucosal immune responses in calves orally vaccinated with a live auxotrophic aroA Salmonella dublin strain.

Segall T, Jacobsson SO, Karlsson K, Lindberg AA.

Zentralbl Veterinarmed B. 1994 Jul;41(5):305-12.

PMID:
7839752

Supplemental Content

Loading ...
Support Center